Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. Reports Global Markets Direct’s wide variety of reports offer a targeted solution for marketing and strategic planning.

Sort by


Head And Neck Cancer - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2015’, provides an overview of the Head And Neck Cancer’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Head And Neck Cancer, complete with comparative analysis at var...
$ 2,000.00 Read More

Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Squamous Non-Small Cell Lung Cancer’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Squamous Non-Small Cell Lung Canc...
$ 2,000.00 Read More

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2015’, provides an overview of the Anaplastic Large Cell Lymphoma (ALCL)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Anaplastic Large Cell Lymphom...
$ 2,000.00 Read More

Moderate Pain - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Moderate Pain - Pipeline Review, H1 2015’, provides an overview of the Moderate Pain’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Moderate Pain, complete with comparative analysis at various stages, therapeu...
$ 2,000.00 Read More

Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2015’, provides an overview of the Hospital Acquired Pneumonia (HAP)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hospital Acquired Pneumonia (HAP), co...
$ 2,000.00 Read More

Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2015’, provides an overview of the Human papillomavirus (HPV) Associated Cancer’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Human papilloma...
$ 2,000.00 Read More

Intermittent Claudication - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Intermittent Claudication - Pipeline Review, H1 2015’, provides an overview of the Intermittent Claudication’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Intermittent Claudication, complete with comparative ...
$ 2,000.00 Read More

Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H1 2015’, provides an overview of the Venous Leg Ulcers (Crural ulcer)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Venous Leg Ulcers (Crural ulcer), compl...
$ 2,000.00 Read More

Plague - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Plague - Pipeline Review, H1 2015’, provides an overview of the Plague’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Plague, complete with comparative analysis at various stages, therapeutics assessment by dr...
$ 2,000.00 Read More

Colitis - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Colitis - Pipeline Review, H1 2015’, provides an overview of the Colitis’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Colitis, complete with comparative analysis at various stages, therapeutics assessment by...
$ 2,000.00 Read More

Urinary Tract Infections - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Urinary Tract Infections - Pipeline Review, H1 2015’, provides an overview of the Urinary Tract Infections’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Urinary Tract Infections, complete with comparative ana...
$ 2,000.00 Read More

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015’, provides an overview of the Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer’s therapeutic pipeline.This report provides compre...
$ 2,000.00 Read More

Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2015’, provides an overview of the Reflux Esophagitis (Gastroesophageal Reflux Disease)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for...
$ 2,000.00 Read More

Indolent Lymphoma - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Indolent Lymphoma, complete with comparative analysis at various stag...
$ 2,000.00 Read More

Epilepsy - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Epilepsy - Pipeline Review, H1 2015’, provides an overview of the Epilepsy’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Epilepsy, complete with comparative analysis at various stages, therapeutics assessment...
$ 2,000.00 Read More
Total 4738 records.